Press Releases

Ovid has expanded its partnership with Oxford University Press (OUP) to add more than 180 titles in medicine, neurosciences, social and behavioural sciences to Books@Ovid, its e-books search and discovery platform.

Elsevier has partnered with SOAPware to allow Elsevier’s iCONSULT clinical decision support content to be offered as a Clinical Knowledge Module to SOAPware v5 (liger) EHR users.

International Journal of Biomedical Sciences (IJBS) is a new quarterly, open-access journal focusing on theories, methods and applications in biomedical sciences, computational and systems biology.

The Public Library of Science (PLoS) has created PLoS Neglected Tropical Diseases, said to be the first open-access journal devoted to the world’s most neglected diseases.

Unbound Medicine has released The Merck Manual for Mobile Devices in partnership with Merck & Co.

Springer has entered into a partnership with the Society for In Vitro Biology and the International Association for Plant Biotechnology to publish two In Vitro journals.

Unbound Medicine and the BMJ Publishing Group have released an upgraded BMJ Clinical Evidence for mobile devices.

Springer is launching the Journal of Robotic Surgery. This new journal is expected to be the first to focus exclusively on emerging robotic applications in surgery.

John Wiley & Sons has teamed up with Microsoft Learning to develop, publish, and deliver Microsoft Official Academic Curriculum (MOAC) textbooks and e-learning tools to the higher education market.

NetLibrary has announced the availability of new science, technology and medicine titles from CRC Press, resulting in 1,000 additional STM titles being added to the NetLibrary catalogue each year.

SAGE Publications has produced SAGETRACK, a web-based peer review and submission system powered by ScholarOne’s Manuscript Central.

Elsevier has launched a new online-only oncology review journal. Update on Cancer Therapeutics will be published quarterly and is intended for clinicians working in clinical oncology and cancer therapeutics.